Apotea AB (publ) (STO:APOTEA)
Sweden
· Delayed Price · Currency is SEK 67.05
+1.65 (2.52%)
At close: Apr 28, 2026
Apotea AB Revenue
In the year 2025, Apotea AB had annual revenue of 7.21B SEK with 10.06% growth. Apotea AB had revenue of 1.86B in the quarter ending December 31, 2025, with 6.76% growth.
Revenue
7.21B
Revenue Growth
+10.06%
P/S Ratio
0.97
Revenue / Employee
9.91M
Employees
727
Market Cap
6.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.21B | 658.30M | 10.06% |
| Dec 31, 2024 | 6.55B | 1.09B | 20.01% |
| Dec 31, 2023 | 5.46B | 572.40M | 11.72% |
| Dec 31, 2022 | 4.88B | 303.30M | 6.62% |
| Dec 31, 2021 | 4.58B | 1.74B | 61.34% |
| Dec 1, 2019 | Pro | Pro | Pro |
| Dec 1, 2018 | Pro | Pro | Pro |
| Dec 1, 2017 | Pro | Pro | Pro |
| Dec 1, 2016 | Pro | Pro | Pro |
| Dec 1, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 28.24B |
| Getinge AB | 34.09B |
| Sectra AB | 3.52B |
| Camurus AB | 2.27B |
| Ambea AB | 16.11B |
| Dynavox Group AB | 2.47B |
| Xvivo Perfusion AB | 834.53M |
| Synsam AB | 7.07B |
Apotea AB News
- 3 months ago - Apotea AB Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Apotea AB Earnings Call Transcript: Q3 2025 - Transcripts
- 10 months ago - Apotea AB Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Apotea AB Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Apotea AB Earnings Call Transcript: Q4 2024 - Transcripts